Small-molecule agents for cancer immunotherapy
Cancer immunotherapy, exemplified by the remarkable clinical benefits of the immune checkpoint blockade and chimeric antigen receptor T-cell therapy, is revolutionizing cancer therapy. They induce long-term tumor regression and overall survival benefit in many types of cancer. With the advances in o...
Saved in:
Main Authors: | Fang Wang (Author), Kai Fu (Author), Yujue Wang (Author), Can Pan (Author), Xueping Wang (Author), Zeyu Liu (Author), Chuan Yang (Author), Ying Zheng (Author), Xiaopeng Li (Author), Yu Lu (Author), Kenneth Kin Wah To (Author), Chenglai Xia (Author), Jianye Zhang (Author), Zhi Shi (Author), Zeping Hu (Author), Min Huang (Author), Liwu Fu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenic cell death‐inducing small molecule inhibitors: Potential for immunotherapy of cancer
by: Zong Sheng Guo, et al.
Published: (2022) -
Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities
by: Zeyu Han, et al.
Published: (2024) -
Small-Molecule Fluorescent Probe for Detection of Sulfite
by: Ting Li, et al.
Published: (2022) -
Rociletinib (CO-1686) enhanced the efficacy of chemotherapeutic agents in ABCG2-overexpressing cancer cells in vitro and in vivo
by: Fanpu Zeng, et al.
Published: (2020) -
Self-assembled small molecule natural product gel for drug delivery: a breakthrough in new application of small molecule natural products
by: Kangkang Zhi, et al.
Published: (2020)